ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

September 13, 1985

Symposium Planned On Hyperthermia

April 23, 1976

BRMP Proposals for Thymosins Development

November 30, 1979

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

November 2, 1990

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983